Can perhexiline be utilized without long-term toxicity? A clinical practice audit

H Phuong, BY Choi, CR Chong, B Raman… - Therapeutic drug …, 2016 - journals.lww.com
Background: Perhexiline, originally used as a first-line prophylactic antianginal agent, is now
regarded primarily as a treatment for otherwise refractory myocardial ischemia. Recent …
被引用次数：17 相关文章

Can perhexiline be utilized without long-term toxicity? A clinical practice audit

H Phuong, B Choi, C Chong, B Raman, J Horowitz - 2016 - digital.library.adelaide.edu.au
Background: Perhexiline, originally used as a first-line prophylactic antianginal agent, is now
regarded primarily as a treatment for otherwise refractory myocardial ischemia. Recent …

Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit.

H Phuong, BY Choi, CR Chong, B Raman… - Therapeutic Drug …, 2016 - europepmc.org
Background Perhexiline, originally used as a first-line prophylactic antianginal agent, is now
regarded primarily as a treatment for otherwise refractory myocardial ischemia. Recent …

Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit

H Phuong, BY Choi, CR Chong… - Therapeutic drug …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Perhexiline, originally used as a first-line prophylactic antianginal agent, is now
regarded primarily as a treatment for otherwise refractory myocardial ischemia. Recent …

Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit

H Phuong, BY Choi, CR Chong, B Raman… - Therapeutic Drug …, 2016 - journals.lww.com
Background: Perhexiline, originally used as a first-line prophylactic antianginal agent, is now
regarded primarily as a treatment for otherwise refractory myocardial ischemia. Recent …